Day: July 1, 2022

HENDERSON, NV, July 01, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Grove, Inc. (NASDAQ:GRVI) (“Grove” or the “Company”), today announced that it has completed a strategic debt investment to fund future growth. Under the terms of the loan, the Company, at the initial closing, drew $7.5 million of the $15 million available. The Company could draw down against the remainder should it be needed to fund further profitable acquisitions in the future. The loan amortizes over 30 months and bears interest at a rate of 13% per annum, 8.5% payable in cash on the first day of each month hereafter and 3.5% PIK payable each month in arrears. There are fees, financial covenants, and prepayment fees associated with the loan, as well as a security agreement and other related agreements. As part of the terms of the loan,...

Incap Corporation                  Press release                1 July 2022 at 3:30 p.m. EESTThe corrected release includes the time of the webcast. Incap Group’s half-year financial report for January–June 2022 will be published on Thursday, 28 July 2022 at approximately 09:00 a.m. Finnish time. At that time, reporting materials in Finnish and English will be available on the company’s website at https://incapcorp.com/reports-and-presentations/. WebcastThe company will hold a webcast on Thursday, 28 July 2022 at 2:00 p.m. EEST. The result will be presented by Otto Pukk, CEO, and Antti Pynnönen, CFO, Incap Corporation. In addition to the result, Incap’s UK operations will be presented at the event, and Jamie Maughan, Director of Operations UK will participate in the event. The live webcast can be followed at https://incap.videosync.fi/2022-07-28-half-year-report....

Eventer will leverage its capabilities in the sports sector and intends to expand its outreach to leagues in the US and Europe Tel Aviv, Israel, July 01, 2022 (GLOBE NEWSWIRE) —  Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that Eventer Technologies Ltd. (“Eventer”), a software company operating events and virtual events sector, 47.69% owned by Medigus, signed agreements with two basketball teams from the Israeli Basketball Premier League and the Israeli National Basketball League. As part of the agreements, Eventer will sell tickets for the teams’ games. Eventer has recently expanded its presence in the entertainment field by offering its services to teams and...

Biomea to present two oral abstracts across multiple animal models highlighting the ability of BMF-219, a covalent menin inhibitor, to significantly lower HbA1C (approximately two-fold greater reduction than active control, liraglutide) and to increase beta cell function. BMF-219 showed prolonged glycemic control in two standard diabetes animal models, the Zucker Diabetic Fatty (ZDF) and Streptozotocin-induced (STZ) Rat models, throughout the dosing period and, additionally, glycemic control was maintained after the dosing period ended. Oral Presentations to include additional data not released in the two posters presented at the American Diabetes Association Scientific Sessions on June 4, 2022. Biomea expects to initiate a Phase I/II clinical trial of BMF-219 in type 2 diabetes in the second half of 2022, subject to IND submission and...

BEVERLY, Mass., July 01, 2022 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the MiQLab® System for automated, multiplexing PCR-based syndromic testing in veterinary clinics, is pleased to announce that it has entered into a purchase agreement with a veterinary hospital in Wisconsin. Dr. Jack Regan, LexaGene’s CEO and Founder stated, “We are pleased to announce this sale to a veterinary hospital in Wisconsin. Once we complete our scheduled installations, we will have MiQLab Systems operating in 10 states across the US. Since the start of this year, our install base has increased 240% and we expect an even steeper increase in the latter part of this year.” To learn more about LexaGene and the MiQLab System or subscribe...

FLSmidth has won a contract to supply a series of state-of-art equipment for a greenfield cement plant in Asia. The order is valued at more than DKK 400 million and has been booked in Q2 2022. The equipment will be supplied during 2023. The contract includes among other technologies; the FLSmidth OKTM Raw Mill, OKTM Cement Mill and Low NOx ILC preheater, which are flagships in FLSmidth’s MissionZero programme for Cement. “This project showcases FLSmidth’s ability to deliver energy efficient technologies across the full cement flowsheet and thereby supporting our customers in both increasing capacity and their sustainability efforts,” says Carsten Riisberg Lund, Cement Industry President, FLSmidth.Contacts: Investor RelationsJannick Lindegaard Denholt, +45 21 69 66 57, jli@flsmidth.comTherese Möllevinge, +45 41 37 16 38, tmo@flsmidth.comMikkel...